Vicarious Surgical Inc., a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced that it has signed an agreement with...
Modalis Therapeutics Corporation, a pioneering company developing innovative products for the treatment of rare genetic diseases utilizing its proprietary CRISPR-GNDM® epigenome editing technology, announced its recognition...
Early Regulatory Approval Accelerates Expansion Plans in Europe and the Middle East VUNO, a leading South Korean medical AI company, announced today that its flagship AI-powered cardiac arrest...
A groundbreaking international study has mapped over 400 distinct human cell types, providing powerful validation for Prof. Mike Chan’s longstanding vision of organ-specific, cell-specific regenerative medicine. This...
Liberate, the leading conversational voice AI platform designed to transform the insurance industry, has announced a new partnership and pre-built integration with Snapsheet, an industry...
ZEISS and Alpenglow Biosciences partner for co-development of 3D pathology solution ZEISS and Alpenglow Biosciences today announced a new partnership to jointly develop an inverted...
bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW) a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced that it has...
Astraveus SAS (“Astraveus” or the “Company”), the benchtop cell factory company, today announces that it has entered into a strategic partnership with The Netherlands Center...
Partners with Company Management and Thoma Bravo to Support NextGen Healthcare’s Growth Madison Dearborn Partners, LLC (“MDP”), a leading private equity investment firm based in...
The company will showcase innovations designed to optimize the oncology care workflow and enable improved patient outcomes GE HealthCare (Nasdaq: GEHC) today announced an intended...
Fullscript, a leading healthcare platform powering whole person care, today announced an expanded investment from HGGC, a leading middle-market private equity firm, and Snapdragon Capital...
Along with PCI’s own robust infrastructure expansions, acquisition furthers CDMO’s recent growth in sterile fill-finish, advanced drug delivery systems like prefilled syringes and cartridges, and...
OcuSciences, Inc., a leader in advanced ocular diagnostics, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for its flagship device,...
Insight Partners leads round with participation from existing investors Afore Capital, Crossbeam Venture Partners, and Metrodora Ventures, bringing total funding to $32.5M to fuel Blooming Health’s AI-driven...